MPLW515L mutation in acute megakaryoblastic leukaemia

Leukemia

Volumn 23, Issue 5, 2009, Pages 852-855

  Hussein, K ^a   Bock, O ^a   Theophile, K ^a   Schulz Bischof, K ^a   Porwit, A ^b   Schlue, J ^a   Jonigk, D ^a   Kreipe, H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE 2; THROMBOPOIETIN RECEPTOR; JAK2 PROTEIN, HUMAN; MPL PROTEIN, HUMAN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MEGAKARYOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CHROMOSOME ABERRATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; MALE; MEGAKARYOCYTE; MUTATIONAL ANALYSIS; MYELOID METAPLASIA; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PYROSEQUENCING; TRISOMY 21; BLAST CELL CRISIS; BONE MARROW CELL; GENETICS; LASER; MICRODISSECTION; MIDDLE AGED; MUTATION; PRESCHOOL CHILD;

ADULT; AGED; AGED, 80 AND OVER; BLAST CRISIS; BONE MARROW CELLS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; JANUS KINASE 2; LASERS; LEUKEMIA, MEGAKARYOBLASTIC, ACUTE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MICRODISSECTION; MIDDLE AGED; MUTATION; PRIMARY MYELOFIBROSIS; RECEPTORS, THROMBOPOIETIN;

EID: 66849103934     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.371     Document Type: Article

References (14)

1. Oki Y, Kantarjian HM, Zhou X, Cortes J, Faderl S, Verstovsek S et al Adult acute megakaryocytic leukemia: An analysis of 37 patients treated at MD Anderson Cancer Center. Blood 2006; 107: 880-884.
2. Orazi A. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/ myeloproliferative diseases. Pathobiology 2007; 74: 97-114.
3. Steensma DP, McClure RF, Karp JE, Tefferi A, Lasho TL, Powell HL et al. JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained. Leukemia 2006; 20: 971-978.
4. Schnittger S, de Sauvage FJ, Le Paslier D, Fonatsch C. Refined chromosomal localization of the human thrombopoietin gene to 3q27-q28 and exclusion as the responsible gene for thrombocytosis in patients with rearrangements of 3q21 and 3q26. Leukemia 1996; 10: 1891-1896.
5. Malinge S, Ragu C, Delia-Valle V, Pisani D, Constantinescu SN, Perez C et al. Activating mutations in human acute megakaryoblastic leukemia. Blood 2008; 112: 4220-4226; [e-pub ahead of print].
6. Pardanani AD, Levine RL, Lasho T, Pikman Y, Mesa RA, Wadleigh M et al MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood 2006; 108: 3472-3476.
7. James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C et al A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005; 434: 1144-1148.
8. Jelinek J, Oki Y, Charibyan V, Bueso-Ramos C, Prchal JT, Verstovsek S et al. JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosomenegative CML, and megakaryocytic leukemia. Blood 2005; 106: 3370-3373.
9. Nishii K, Nanbu R, Lorenzo VF, Monma F, Kato K, Ryuu H et al. Expression of the JAK2 V617F mutation is not found in de novo AML and MDS but is detected in MDS-derived leukemia of megakaryoblastic nature. Leukemia 2007; 21: 1337-1338.
10. Fröhling S, Lipka DB, Kayser S, Scholl C, Schlenk RF, Döhner H et al. Rare occurrence of the JAK2 V617F mutation in AML subtypes M5, M6, and M7. Blood 2006; 107: 1242-1243.
11. Bock O, Lehmann U, Kreipe H. Quantitative intra-individual monitoring-of BCR-ABL transcript levels in archival bone marrow trephines of patients with chronic myeloid leukemia. J Mol Diagn 2003; 5: 54-60.
12. Norton A, Fisher C, Liu H, Wen Q, Mundschau G, Fuster JL et al. Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome. Blood 2007; 110: 1077-1079.
13. Bocchia M, Vannucchi AM, Gozzetti A, Guglielmelli P, Poli G, Crupi R et al. Insights into JAK2-V617F mutation in CML. Lancet Oncol 2007; 8: 864-866.
14. Hussein K, Bock O, Theophile K, Seegers A, Arps H, Basten O et al. Chronic myeloproliferative diseases with concurrent BCR-ABL junction and JAK2V617F mutation. Leukemia 2008; 22: 1059-1062.